Veracyte, Inc.

VCYTNASDAQ

Healthcare · Services-medical Laboratories

Market cap

$3.55B

Employees

755

Exchange

NASDAQ

Headquarters

SOUTH SAN FRANCISCO, CA

About Veracyte, Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Industry

Services-medical Laboratories

Sector

Healthcare

Country

US

Website

www.veracyte.com